You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adjuvant therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

COVID-19 Trial in Hohhot (Graphene spectrum light wave therapy room)

Recruiting
  • COVID-19
  • Graphene spectrum light wave therapy room
  • Hohhot, Inner Mongolia, China
    Hohhot First Hospital
Dec 7, 2022

Hormone Receptor-positive Advanced Breast Cancer Trial (chidamide combined with fulvestrant)

Not yet recruiting
  • Hormone Receptor-positive Advanced Breast Cancer
  • chidamide combined with fulvestrant
  • (no location specified)
Mar 28, 2023

Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy

Recruiting
  • Urothelial Carcinoma
  • Radiotherapy
  • +2 more
  • Beijing, China
  • +2 more
Nov 2, 2023

Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

Not yet recruiting
  • Liver Transplant; Complications
  • +3 more
  • multi-kinase inhibitors in combination with bevacizumab
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023

Male Reproductive Problem, Infertility, Male Trial in Baghdad (Letrozole tablets, Coenzyme Q10 table)

Completed
  • Male Reproductive Problem
  • Infertility, Male
  • Letrozole tablets
  • Coenzyme Q10 table
  • Baghdad, Iraq
    specialized center of infertility/ Nahrain University
Apr 26, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01 in combination with standard adjuvant therapy
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)

Not yet recruiting
  • Endometrial Cancer
  • Vaginal brachytherapy
  • +2 more
  • (no location specified)
Nov 29, 2022

Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation

Recruiting
  • Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Jan 4, 2023

Knee Osteoarthritis Trial in Tanta (Placebo Tablet, Metformin Hcl 500Mg Tab)

Completed
  • Knee Osteoarthritis
  • Placebo Tablet
  • Metformin Hcl 500Mg Tab
  • Tanta, Gharbia, Egypt
    Tanta university
Dec 5, 2022

Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)

Recruiting
  • Serplulimab,Gastric Cancer, Adjuvant Therapy
  • Shanghai, China
    Zhang Zizhen
Mar 3, 2023

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Adjuvant Immune Checkpoint Inhibitors in Postoperative

Recruiting
  • Hepatocellular Carcinoma
  • Immune Checkpoint Inhibitors Based Adjuvant therapy
  • Nanning, Guangxi, China
    Jian-Hong Zhong
Jan 18, 2023

Ulcerative Colitis Trial in Shibin Al Kawm (Empagliflozin 10 MG, Placebo)

Recruiting
  • Ulcerative Colitis
  • Empagliflozin 10 MG
  • Placebo
  • Shibīn Al Kawm, Menoufia, Egypt
    Faculty of Pharmacy
Oct 25, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 17, 2023

Status Epilepticus Trial in Albuquerque, Cincinnati, Columbus (IV Ganaxolone, IV Placebo)

Not yet recruiting
  • Status Epilepticus
  • IV Ganaxolone
  • IV Placebo
  • Albuquerque, New Mexico
  • +2 more
Mar 8, 2023

N-Acetylcysteine asAdjuvant Therapy in Critically Ill COVID-19

Not yet recruiting
  • COVID-19 Pneumonia
    • (no location specified)
    Aug 15, 2022

    Breast Cancer Female, Triple Negative Breast Cancer Trial (quercetin, EGCG, metformin , zinc)

    Not yet recruiting
    • Breast Cancer Female
    • Triple Negative Breast Cancer
    • quercetin, EGCG, metformin , zinc
    • (no location specified)
    Dec 23, 2022

    Stereotactic Body Radiation Therapy Trial in Beijing (drug adjuvant therapy)

    Not yet recruiting
    • Stereotactic Body Radiation Therapy
    • drug adjuvant therapy
    • Beijing, Beijing, China
      Department of Radiation Oncology Cancer Center, Peking Universit
    Jun 6, 2022

    Parkinson Disease Trial in Tanta (Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers)

    Recruiting
    • Parkinson Disease
    • Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers
    • Tanta, El Gharbia, Egypt
      Tanta University
    Oct 10, 2022

    Breast Cancer Trial in Beijing, Guangzhou (TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen, Placebo capsules, Letrozole,

    Not yet recruiting
    • Breast Cancer
    • TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen
    • Placebo capsules, Letrozole, Anastrozole, Tamoxifen
    • Beijing, Beijing, China
    • +1 more
    Mar 10, 2023

    Esophagus Cancer Trial in Tianjin (Camrelizumab, Paclitaxel, Cisplatin)

    Recruiting
    • Esophagus Cancer
    • Tianjin, Tianjin, China
      Affiliated Cancer Hospital of Tianjin Medical University
    Nov 24, 2022

    MSI-H, PD-1 Immunotherapy, Gastric Cancer Trial in Shanghai (SOX, XELOX, Observation)

    Not yet recruiting
    • MSI-H
    • +3 more
    • Shanghai, China
      Dazhi Xu
    Jul 20, 2022

    Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

    Recruiting
    • Non-clear Renal Cell Carcinoma
    • Nanjing, Jiangsu, China
    • +1 more
    Mar 13, 2023

    Melanoma Trial (Blood samples, Skin biopsy)

    Not yet recruiting
    • Melanoma
    • Blood samples
    • Skin biopsy
    • (no location specified)
    Oct 3, 2022